In vitro models to study hepatotoxicity.
Drug discovery and development consists of a series of processes starting with the demonstration of pharmacological effects in experimental cell and animal models and ending with drug safety and efficacy studies in patients. A main limitation is often the unacceptable level of toxicity with the liver as the primary target organ. Therefore, approaches to study hepatic toxicity in the early phase of drug discovery represent an important step towards rational drug development. A variety of in vitro liver models have been developed in the past years. Next to their use in drug development, they can also be applied to study environmental toxins and their hepatotoxicity. The 3 main approaches are ex vivo isolated and perfused organ models, precision-cut liver slices and cell culture models. Although the advantage of whole organ perfusions is based on the assessment of physiologic parameters such as bile production and morphologic parameters such as tissue histology, cell culture models can be efficiently used to assess cellular metabolism, cytotoxicity and genotoxicity. The advantage of precision-cut liver slices is based on the juxtaposition of cellular assays and tissue morphology. None of these models can be compared as they all focus on different fields of hepatoxicology. For the future, the ideal setup for testing the hepatic toxicity of a new compound could of primary studies in cell or slice cultures to assess cellular effects and secondary studies using ex vivo perfused organs to examine gross organ function parameters and histology.
Groneberg
David A
DA
Department of Pediatric Pneumology and Immunology, Charité School of Medicine, Humboldt-University Berlin, Germany. david.groneberg@charite.de
Grosse-Siestrup
Christian
C
Fischer
Axel
A
D018929:Cell Culture Techniques / Q000379:methods; D004353:Drug Evaluation, Preclinical; D008099:Liver / Q000187:drug effects*; D009924:Organ Culture Techniques / Q000379:methods; D014116:Toxicology / Q000379:methods*